Showing 1 - 10 of 180
Persistent link: https://www.econbiz.de/10010251098
Persistent link: https://www.econbiz.de/10012657757
Persistent link: https://www.econbiz.de/10012258540
Persistent link: https://www.econbiz.de/10012492743
Persistent link: https://www.econbiz.de/10012194757
The U.S. Food and Drug Administration (FDA) balances risks and benefits before approving pharmaceuticals, as …
Persistent link: https://www.econbiz.de/10014148944
Will a major shock awaken US citizens to the threat of catastrophic pandemic risk? Using a natural experiment administered both before and after the 2014 West African Ebola Outbreak, our evidence suggests “no”. Our results show that prior to the Ebola scare, US citizens were relatively...
Persistent link: https://www.econbiz.de/10012838191
The COVID-19 pandemic poses novel health issues. However, the benefits and costs of the pandemic and policies to address it have a familiar economic structure. Chief among the health-related benefits are the monetized values of the U.S. mortality costs of $3.9 trillion in 2020. The combined U.S....
Persistent link: https://www.econbiz.de/10013247339
Persistent link: https://www.econbiz.de/10000935383
Persistent link: https://www.econbiz.de/10000851786